اجتمع الرئيس الصيني Xi Jinping مع قادة الاتحاد الأوروبي خلال زيارتهم إلى بكين للمشاركة في القمة الخامسة والعشرين بين الصين والاتحاد الأوروبي، التي عُقدت يوم الخميس، ونشرت CGTN مقالاً تناولت فيه علاقات الصين والاتحاد الأوروبي في مجاليّ التجارة والاستثمار المتبادلين، مؤكدةً على ضرورة تمسك الجانبين بالتعددية والانفتاح والتعاون من أجل تحقيق قدر أكبر من الاستقرار واليقين في العالم. بكين, July 27, 2025 (GLOBE NEWSWIRE) — قبل خمسين عامًا، كانت التجارة بين الصين وأوروبا محدودة جدًا، واليوم، ومع احتفال الجانبين بمرور نصف قرن على علاقاتهما، أصبحت تجارة يوم واحد تعادل حجم التبادل التجاري الذي تم خلال عام كامل عندما تأسست تلك

NEW YORK, July 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd. (NYSE: BHVN) between March 24, 2023 and May 14, 2025, both dates inclusive (the “Class Period”), of the important September 12, 2025 lead plaintiff deadline. SO WHAT: If you purchased Biohaven securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Biohaven class action, go to https://rosenlegal.com/submit-form/?case_id=41650 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information.

NEW YORK, July 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) pursuant and/or traceable to Alto’s initial public offering conducted on or about February 2, 2024 (the “IPO”); and/or (ii) securities between February 2, 2024 and October 22, 2024, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than September 19, 2025. SO WHAT: If you purchased Alto securities you may be

NEW YORK, July 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Vestis Corporation (NYSE: VSTS) between May 2, 2024 and May 6, 2025, both dates inclusive (the “Class Period”), of the important August 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased Vestis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Vestis class action, go to https://rosenlegal.com/submit-form/?case_id=25291 or call Phillip Kim, Esq. at 866-767-3653 or

NEW YORK, July 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline. SO WHAT: If you purchased Sarepta securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Sarepta class action, go to https://rosenlegal.com/submit-form/?case_id=20094 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more

NEW YORK, July 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Fiserv, Inc. (NYSE: FI) between July 24, 2024 and July 22, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 22, 2025. SO WHAT: If you purchased Fiserv common stock during the Class Period you may be entitled to compensation without payment of any out of